Adilet Nazarbayev, General Director of Johnson & Johnson Kazakhstan LLP, was elected to the Board of Directors of the American Chamber of Commerce (AmCham) in Kazakhstan. AmCham is a leading business association representing the interests of major companies from the United States, Europe and Asia. By actively developing partnerships between member companies and the government, AmCham Kazakhstan helps strengthen trade and economic ties between Kazakhstan and the global community and unites more than 200 members.
“Joining AmCham Board of Directors is a great honour for me. I am grateful for the support of my candidature and will make every effort to ensure that my management experience at Johnson & Johnson and expertise in healthcare become a useful contribution to the strategic development of the association. I am convinced that working together within the organisation will further strengthen the business community, the country's economy in general and the well-being of the people of Kazakhstan”, - Adilet Nazarbayev comments.
Adilet joined Janssen, the pharmaceutical products division of Johnson & Johnson LLC, in 2005, beginning his career as a sales representative. During these years of service, he held key positions on the sales and market access teams. In 2014, Adilet took up the position of Janssen Head of Kazakhstan, from 2019 he was promoted to Head of Business Development for CIS and Ukraine, responsible for the strategic development of the company in the countries of the region. In 2019, he received the “Excellence in Healthcare” (“Денсаулық сақтау ісінің үздігі”) comme ndation from the Minister of Health of the Republic of Kazakhstan for his contribution to public health and active participation in improving the country's healthcare system. In January 2021 Adilet took the position of Janssen CIS Country Director and from the beginning of 2024 he became the head of an independent local legal entity Johnson & Johnson Kazakhstan LLP. For several years Adilet has been actively engaged in AmCham’s work in Kazakhstan. He is leading the AmCham Intellectual Property Rights (Pharmaceuticals) Working Group, which meets regularly with the Health Minister and Deputy Minister.
About Johnson & Johnson Kazakhstan LLP
Johnson & Johnson Kazakhstan LLP is part of the global Johnson & Johnson Corporation, the largest healthcare company in the world.
At Janssen, we are creating a future where diseases are a thing of the past. We spare no effort to make this future a reality for patients around the world. We conquer disease with cutting-edge science, make therapies more accessible with ingenuity, and heal hopelessness with human warmth. We focus on the areas of medicine where we can do the most good: cardiovascular disease, metabolic and ophthalmic disorders, immune-mediated conditions, infectious diseases and vaccines, neurology, oncology and pulmonary arterial hypertension.
Read more at https://www.janssen.com/
